Retaglutide is a novel GLP-1 receptor agonist currently under study for the management of metabolic disorders. This therapy works by enhancing the effects of glucagon-like peptide-1 (GLP-1), a naturally occurring https://kiaraciql970950.uzblog.net/trelaglutide-exploring-a-new-therapy-for-chronic-diseases-52556494